In California, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, used the gene-editing tool, CRISPR, to reprogram mutated rod photoreceptors and restoring vision in two mouse models. Retinitis pigmentosa is an inherited vision disorder resulting from genetic mutation in more than 60 genes making it difficult for night vision, peripheral vision, color discernment and central vision. It affects about 1 in 4,000 people globally with the eventual result possibly becoming legal blindness and there is no current treatment for it. The ability of researchers to shut off or deactivate certain gene “switches” allowed them to modify select genes to restore vision. They hope to perform clinical trials on humans soon since there is no other treatment or cure for retinitis pigmentosa currently.
Latest article
Fin-ished, for now: Aqua Cultured Foods shutters as funding dries up
In Chicago, a fermentation startup converting cellulose into seafood alternatives has wound down operations after failing to raise funds necessary to reach commercialization.
Established...
Mercedes unveils vegan-interior SUV at CES
In Nevada, Mercedes-Benz has showcased a new, vegan-interior GLC electronic SUV at the recent CES technology trade show in Las Vegas.
Vegan materials were...
Futerro files permits for French PLA site
In France, biobased chemicals maker Futerro has requested the relevant permits for its planned lactic acid and polylactic acid plant in France.
The plant, which...